24 February 2026 : Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
I-Ji Jeong
BCEF 1, Shin Hwang ABDEF 1*, Chul-Soo Ahn BCD 1, Deok-Bog Moon BCD 1, Tae-Yong Ha ABCD 1, Gi-Won Song BCD 1, Dong-Hwan Jung BCD 1, Gil-Chun Park BCD 1, Woo-Hyoung Kang BCD 1, Young-In Yoon BCD 1, Sung-Gyu Lee BD 1
DOI: 10.12659/AOT.950997
Ann Transplant 2026; 31:e950997
Figure 1 All-type tumor recurrence (A) and overall patient survival (B) curves for 25 liver transplant recipients with intrahepatic cholangiocarcinoma with or without concurrent hepatocellular carcinoma or combined hepatocellular carcinoma-cholangiocarcinoma. All-type tumor recurrence includes any recurrence of intrahepatic cholangiocarcinoma or concurrent tumors.